Surgical valve technologies
Surgical valve technologies Transcatheter heart valves technologies
Risk factors and predictive models for post-operative moderate-to-severe mitral regurgitation following transcatheter aortic valve replacement: a machine learning approach
Abstract Background Post-operative moderate-to-severe mitral regurgitation (MR) following transcatheter aortic valve replacement (TAVR) is associated with poor outcomes, yet the
Surgical valve technologies Transcatheter heart valves technologies
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI)
Abstract Background Acute kidney injury (AKI) following transcatheter aortic valve implantation (TAVI) is associated with significantly worse outcomes, leading to
Abstract Background Minimally invasive mitral valve surgery (MIMVS) is increasingly performed, but outcomes such as repair rate, mortality and survival
Abstract Objective To evaluate the clinical efficacy of an modified surgical technique using scleral tunneling and Tenon’s capsule for implantation
Abstract Background The incidence of infective endocarditis (IE) in patients undergoing redo mitral valve (MV) surgery was evaluated. The outcomes
Abstract Introduction Stroke is a potentially debilitating complication of heart valve replacement surgery, with rates ranging from 1 to 10%.
Abstract Objectives To identify independent predictors of late recurrence of atrial fibrillation (AF) after surgical ablation in patients undergoing rheumatic
Abstract Objectives Transcatheter edge-to-edge repair (TEER) is an alternative for patients with severe degenerative mitral regurgitation (MR). The objective of
Abstract Objective Patients on direct-acting oral anticoagulants (DOACs) are at high risk of perioperative bleeding complications. Intraoperative hemoadsorption is a
